Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07410689 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date: Jun 2026 to Sep 2026 · Eligibility criteria expanded, about 9 words · Secondary endpoints: details revised at 4 of 5 entries · 3 more Show 6 more changesShow less
    • Start date: Jun 2026 to Sep 2026
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 4 of 5 entries
    • Study description revised
    • Site details revised
    • Publications: details revised at 32 of 35 entries
  2. Start date: May 2026 to Jun 2026v3
  3. Start date: Mar 2026 to May 2026v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized, two-arm, parallel-group pilot trial investigating a new chatbot tool designed to support cancer patients and caregivers, particularly those in rural communities. Approximately 60 participants will be randomized 1:1 to interact with either a hybrid chatbot or an AI-enabled chatbot. Participants will use their assigned chatbot to obtain clear and helpful information related to insurance, travel costs, and other financial aspects of cancer care.
Trial Details
NCT Number NCT07410689
Lead Sponsor University of Utah
Collaborators: Huntsman Cancer Institute
Conditions Cancer, Financial Toxicity
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov